Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Plexus reports after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual earnings data.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-07-29 | -$9.59 (-3.83%) | $18.45 (7.38%) | +$1.50 (+0.62%) | $21.51 (8.94%) |
| 2026-04-29 | +$4.27 (+1.73%) | $8.34 (3.39%) | -$0.02 (-0.01%) | $20.27 (8.09%) |
| 2026-01-28 | +$7.34 (+4.23%) | $8.22 (4.73%) | +$16.75 (+9.26%) | $19.26 (10.65%) |
| 2025-10-22 | -$4.23 (-2.81%) | $5.83 (3.88%) | +$3.76 (+2.57%) | $8.50 (5.82%) |
| 2025-07-23 | +$0.21 (+0.16%) | $1.85 (1.39%) | -$15.54 (-11.61%) | $12.19 (9.11%) |
| 2025-04-23 | +$3.06 (+2.47%) | $3.89 (3.13%) | -$1.82 (-1.43%) | $5.96 (4.69%) |
| 2025-01-22 | +$0.17 (+0.10%) | $2.78 (1.63%) | -$17.19 (-10.08%) | $9.40 (5.51%) |
| 2024-10-23 | +$0.79 (+0.59%) | $1.85 (1.38%) | +$9.32 (+6.87%) | $15.57 (11.48%) |
| Avg Abs Move | 1.99% | 3.36% | 5.31% | 8.04% |
Historical price action shows significant volatility around Plexus earnings, with the stock averaging an absolute move of 5.31% on Day +1 (the first full trading session after results). The Day +1 range has been particularly wide, averaging 8.04%, indicating substantial intraday swings as investors digest the results and guidance.
The pattern reveals mixed directional outcomes but notable magnitude. The largest post-earnings moves came in January 2026 (+9.26% on Day +1) and July 2025 (-11.61% on Day +1), demonstrating the stock's capacity for double-digit swings. More recently, the July 2026 report produced a -3.83% Day 0 move followed by a modest +0.62% Day +1 recovery, while April 2026 saw a +1.73% Day 0 gain that held steady on Day +1.
The 3.36% average Day 0 range and 1.99% average Day 0 absolute move suggest relatively contained anticipatory trading, with the real price discovery occurring after results are released. Investors should prepare for potential moves in the 5-8% range based on historical patterns, with the possibility of larger swings if results or guidance significantly surprise in either direction.
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 24) |
| Expected Move | $10.97 (4.76%) |
| Expected Range | $219.33 to $241.26 |
| Implied Volatility | 48.75% |
The options market is pricing an expected move of 4.76% (approximately $10.97) for the November 20 expiration, which is below the stock's average historical Day +1 move of 5.31% but within the typical range. This suggests options traders are anticipating moderate volatility, though the historical data indicates potential for larger swings, particularly if guidance for fiscal 2027 surprises investors.
Analysts maintain a bullish stance on Plexus heading into earnings, with an average recommendation of 4.43 out of 5.0 (between Buy and Strong Buy). The consensus includes 4 Strong Buy ratings, 2 Moderate Buy ratings, and 1 Hold rating, with no sell recommendations. This positive sentiment has remained unchanged over the past month, reflecting stable conviction in the company's growth trajectory.
The average price target of $305 implies 32.4% upside from the current price of $230.29, with the range spanning from a low of $275 to a high of $330. The $275 low target still suggests 19.4% upside, indicating even the most conservative analyst view sees meaningful appreciation potential. The $330 high target implies 43.3% upside, reflecting optimism about the company's ability to sustain double-digit revenue growth and expand operating margins.
The stability in analyst sentiment—with no changes in rating distribution over the past month—suggests the Street is maintaining its positive thesis despite the stock's recent 16.9% decline. This disconnect between analyst targets and current price levels indicates either that analysts see the pullback as a buying opportunity, or that the market is pricing in execution risks that haven't yet been reflected in formal rating changes. The upcoming earnings report will be critical in determining whether the bullish analyst consensus or the market's recent caution proves more prescient.
The Barchart Technical Opinion has deteriorated significantly heading into earnings, currently showing a 40% Sell signal that has remained unchanged from last week but represents a sharp reversal from the 56% Buy signal just one month ago. This rapid shift from bullish to bearish reflects the stock's recent 16.9% decline and suggests mounting technical pressure.
Timeframe Analysis:
• Short-term (Hold): Neutral reading indicates near-term momentum has stalled after the recent selloff, with no clear directional bias
• Medium-term (50% Sell): Moderate sell signal suggests the intermediate-term trend has turned negative, reflecting weakness over the past several weeks
• Long-term (50% Sell): Moderate sell signal indicates the longer-term trend has also deteriorated, marking a significant shift from the previous bullish structure
Trend Characteristics: The technical environment is characterized by Weak strength and a Weakening direction, indicating deteriorating momentum and fragile support heading into the earnings catalyst.
The stock is trading at $230.29, positioned below most key moving averages: below the 10-day ($231.54), 20-day ($248.52), 50-day ($248.27), and 100-day ($260.06), though it remains above the 5-day ($225.82) and 200-day ($239.56). This configuration shows the stock has broken below intermediate-term support levels while still holding above its longer-term trend line.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $225.82 | 50-Day MA | $248.27 |
| 10-Day MA | $231.54 | 100-Day MA | $260.06 |
| 20-Day MA | $248.52 | 200-Day MA | $239.56 |
The technical setup heading into earnings is cautious, with the stock trapped below a cluster of resistance at the $248-$260 zone (20-day, 50-day, and 100-day moving averages) while testing support near the 200-day moving average at $239.56. The deterioration from a 56% Buy signal to a 40% Sell signal in just one month, combined with positioning below most key moving averages, suggests the stock is vulnerable to further downside if results or guidance disappoint. However, the oversold condition and significant gap between the current price and the $305 analyst target could provide fuel for a sharp reversal if Plexus delivers a strong beat and reaffirms its fiscal 2027 growth outlook. The weak technical strength and weakening direction indicate limited support for the stock absent a positive fundamental catalyst from the earnings report.